Welcome to Symptoma
Symptoma is your digital health assistant.
It helps you understand what might be wrong if you are feeling unwell. Simply state your symptoms and answer questions to find possible medical causes.
Symptoma is based on 16 years of scientific research by medical doctors and data scientists to help patients find possible medical causes for their symptoms.
Today, Symptoma is the most used symptom checker among both, doctors and patients, with millions of users and searches per month. Its diagnostic accuracy is raising the bar in its industry and has been validated in internal, external, and peer-reviewed scientific publications comparing up to 107 solutions worldwide where Symptoma clearly ranked as #1.
Chatbot
Simply state your symptoms and answer questions to find possible medical causes for your symptoms.
Description
Our founder, Jama Nateqi, was invited to speak in the European Parliament (in 2017) and in the German Bundestag (in 2019) about Symptoma and our mission.
Who is Symptoma?
Information
Statement
Statistics
Timeline
Real-World evidence on differentiating COVID-19 symptoms
2022 - March
Symptoma’s study “Symptoms associated with a COVID-19 infection among a non-hospitalized cohort in Vienna” in cooperation with the City of Vienna has been published in The Central European Journal of Medicine.
Award for best cutting-edge research
2021 - September
Symptoma receives the Houska Award as Austrian company with the best cutting-edge research.
European Parliament features Symptoma
2021 - April
The European Parliament features Symptoma as role-model technology against COVID-19.
Austrian Government awards Symptoma
2021 - March
The Austrian government presents Symptoma as the best digital COVID-19 solution from Austria to 40 governments during the United Nations meeting.
European Commission features Symptoma
2021 - March
The European Commission features Symptoma as key player in Europe’s recovery plan.
Austrian Federal Ministry awards Symptoma
2020 - December
The Austrian Federal Ministry for Digital and Economic Affairs awards Symptoma as Austrian Top Digital Innovation.
Collaboration with Austrian medical publisher
2020 - November
The MedTrix Group (one of the biggest Austrian medical publishers) collaborates with Symptoma.
City of Vienna contracts Symptoma to help citizens
2020 - November
The City of Vienna deploys Symptoma to give guidance for Viennese citizens with COVID-19 like symptoms. Huge success with nationwide coverage and 1.5 million questions and answers processed within the first 24h.
Highest accuracy confirmed by peer-reviewed study
2020 - October
JMIR releases Symptoma’s peer-reviewed study “Diagnostic Accuracy of Web-Based COVID-19 Symptom Checkers: Comparison Study” demonstrating that Symptoma’s accuracy is the highest compared to 12 other online tests from all over the globe for identifying the risk of COVID-19 for symptomatic patients.
COVID-19 study published by Nature
2020 - October
Nature publishes Symptoma’s study “An artificial intelligence based first line defence against COVID 19: digitally screening citizens for risks via a chatbot”, proving that Symptoma’s AI correctly assesses the risk of COVID-19 in 96.32% of symptomatic patients.
Our founder becomes the Austrian of the Year 2020
2020 - October
Our CEO and founder, Jama Nateqi, becomes the Austrian of the Year for his research at Symptoma.
Austrian governmental body lists Symptoma’s solution
2020 - September
An Austrian governmental body lists Symptoma on their website as COVID-19 solution next to PCR, Antigen, and Antibody tests.
Insurers and companies contract Symptoma to fight the pandemic
2020 - June
Symptoma supports insurers and companies like the UNIQA Insurance Group in realizing their return-to-office plan and coming back to work safely.
Austrian Government contracts Symptoma to fight the pandemic
2020 - May
The Austrian government contracts Symptoma to help fight the pandemic.
The Digital Health Assistant launches as Medical Device Class I
2020 - May
The Digital Health Assistant launches as a Medical Device Class I per Council Directive 93/42/EEC.
Hospitals contract Symptoma to fight the pandemic
2020 - April
Hospitals like the private clinic Döbling rely on Symptoma’s COVID-19 risk assessment at the building entrance to protect their patients and visitors.
Symptoma adds COVID-19 to main product
2020 - January
The Digital Health Assistant trains for the new disease COVID-19 leading to the first study results published in March 2020 demonstrating 96.32% accuracy in classifying the risk in symptomatic patients. Our first prototype at symptoma.com detects COVID-19 risk in symptomatic patients with 96.32% accuracy (96.66% sensitivity, 96.31% specificity, n = 1142 case reports).
Collaboration with biggest medical publisher in DACH
2019 - October
Major deal signed with the biggest medical publisher in DACH (Thieme) leading to the integration of Symptoma.com in Thieme’s digital world reaching +200k medical professionals and +3,000 institutions (e.g., hospitals) in DACH.
Highest diagnostic accuracy rates
2019 - May
Symptoma ranked #1 in publication of a peer-reviewed performance study.
German Society for Internal Medicine awards Symptoma
2019 - May
The German Society for Internal Medicine designated Symptoma the Lateral Thinker award.
European Commission doubles down on Symptoma
2018
The European Commission chose Symptoma among thousands of SMEs to solve the problem of misdiagnosis. Symptoma received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No 830017.
Eurostars
2017 - November
European Commissions designated Symptoma for the first time as a Eurostars company. Symptoma validated its diagnostic algorithms in cardiology cases with European partners.
Speech in European Parliament
2017 - October
European Commission & EU budget commissioner, Guenther Oettinger, awarded Symptoma as Top 50 EU Company and invited our founder to speak in the European Parlament.
Export Champion
2016 – October
Government of Upper Austria awarded Symptoma as Export Champion.
Top 10 Health Innovation Worldwide
2016 – October
German minister of health, Hermann Gröhe, awarded Symptoma at the World Health Summit 2016.
Best & most promising eHealth solution
2016 - June
Awarded by the European Comission and the Dutch Ministry of Health.
TEDx Talk
2016 - June
The Blindspot in Medicine: Or How to Save 1.5 Million Lives.
Pitch in TV Show
2014
Symptoma’s pitch in Austria’s favorite startup TV became legendary when four of five investors made an offer right on stage.
Pioneers Festival – Top 3
2013 - October
First public pitch. Outmatched more than 1000 startups worldwide. Ran out of business cards and Symptoma made the 3rd place.
Beta-Version of Symptoma released tailored at medical doctors.
2013
Validation study
2012
Standardized testing with hundreds of cases led by the University Hospital of Salzburg, Austria.
Proof of Concept
2009
First performance study conducted.
Alpha-Version of Symptoma
2008
First major deal won
2007
Expanding Symptoma’s R&D team within offices of the incubator “Business Creation Center Salzburg”.
Research & Development started on Symptoma
2006
The idea of Symptoma was born, and the R&D started. Both founders, Thomas Lutz and Jama Nateqi, built a team and committed to helping patients receiving their right diagnosis. With a long-standing track record as co-founders (since 2002) and as successful social entrepreneurs, they had already disrupted the German educational market reaching millions of students per month with a team-size of more than a hundred people.